Skip to content

Immix Biopharma, Inc. IMMX Balance Sheet Statement

FY'25FY'24FY'23FY'22
$93.93M+431%$17.68M+1.0%$17.51M+30.3%$13.44M-23.8%
$6.48M
$101.24M+401%$20.2M+2.1%$19.79M+32.8%$14.9M-18.1%
$2.52M+44.9%$1.74M+3,368%$50.18K+1,310%$3.56K-37.5%
$104.84M+357%$22.95M+15.2%$19.93M+33.7%$14.91M-18.1%
$5.44M+1.0%$5.39M+276%$1.43M+902%$143.07K+0.1%
$10.11M+16.4%$8.69M+133%$3.72M+192%$1.27M+530%
$11.04M$0$0$0-100%
200M0.0%200M0.0%200M0.0%200M0.0%
-$104.46M-39.2%-$75.02M-40.5%-$53.41M-40.6%-$37.99M-27.7%
$93.8M+608%$13.25M-19.2%$16.41M+24.7%$13.16M-26.8%
$104.84M+357%$22.95M+15.2%$19.93M+33.7%$14.91M-18.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Immix Biopharma, Inc.'s total assets?
Immix Biopharma, Inc. (IMMX) holds $95.8M in total assets, up 381.7% year over year.
How much debt does Immix Biopharma, Inc. have?
Immix Biopharma, Inc. carries $1.0M in total debt against $84.4M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Immix Biopharma, Inc. have?
Immix Biopharma, Inc. holds $79.3M in cash and equivalents.
Can Immix Biopharma, Inc. cover its short-term obligations?
Its current ratio is 8.76 — current assets exceed current liabilities.
Where does Immix Biopharma, Inc.'s balance sheet data come from?
Every line is extracted from Immix Biopharma, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.